Proposed biomanufacturing center may create competition among states
The proposed Biomanufacturing Excellence Act of 2025 would establish a single National Biopharmaceutical Manufacturing Center of Excellence within the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST). H.R. 6089 was introduced by Rep. Chrissy Houlahan (D-PA) with bipartisan cosponsors and paired with a Senate companion bill (S. 3188) led by Senators Chris Coons (D-DE) and Ted Budd (R-NC). It authorizes $120 million in FY 2026 for NIST to conduct a competitive process to select one non-federal entity to build and operate the center. Eligible applicants include public-private partnerships, institutions of higher education, and multi-institution consortia. Because only a single awardee will be chosen, the proposed legislation likely sets up what is likely to be a stiff competition among many states which have made life sciences and manufacturing key elements of their innovation strategies.